185 related articles for article (PubMed ID: 19889780)
1. Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.
Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
J Virol; 2010 Jan; 84(2):883-93. PubMed ID: 19889780
[TBL] [Abstract][Full Text] [Related]
2. The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.
Aldrich JF; Shearer MH; Lowe DB; Winn RE; Jumper CA; Kennedy RC; Bright RK
Cancer Immunol Immunother; 2013 Feb; 62(2):371-82. PubMed ID: 22926061
[TBL] [Abstract][Full Text] [Related]
3. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
Kennedy RC; Shearer MH; Watts AM; Bright RK
Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
[TBL] [Abstract][Full Text] [Related]
5. Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes.
Zerrahn J; Utermöhlen O; Warnecke G; Deppert W; Lehmann-Grube F
J Immunol; 1996 May; 156(10):3919-24. PubMed ID: 8621931
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.
Mylin LM; Schell TD; Roberts D; Epler M; Boesteanu A; Collins EJ; Frelinger JA; Joyce S; Tevethia SS
J Virol; 2000 Aug; 74(15):6922-34. PubMed ID: 10888631
[TBL] [Abstract][Full Text] [Related]
7. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
Bright RK; Shearer MH; Kennedy RC
J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
[TBL] [Abstract][Full Text] [Related]
8. In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.
Lowe DB; Shearer MH; Tarbox JA; Kang HS; Jumper CA; Bright RK; Kennedy RC
Virology; 2005 Feb; 332(1):28-37. PubMed ID: 15661138
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.
Aldrich JF; Lowe DB; Shearer MH; Winn RE; Jumper CA; Bright RK; Kennedy RC
J Virol; 2011 Jul; 85(14):7216-24. PubMed ID: 21593176
[TBL] [Abstract][Full Text] [Related]
10. Fc gamma receptors play a dominant role in protective tumor immunity against a virus-encoded tumor-specific antigen in a murine model of experimental pulmonary metastases.
Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
J Virol; 2007 Feb; 81(3):1313-8. PubMed ID: 17108042
[TBL] [Abstract][Full Text] [Related]
11. Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen.
Lowe DB; Shearer MH; Aldrich JF; Winn RE; Jumper CA; Kennedy RC
J Virol; 2010 Oct; 84(19):10121-30. PubMed ID: 20668083
[TBL] [Abstract][Full Text] [Related]
12. Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis.
Watts AM; Shearer MH; Pass HI; Bright RK; Kennedy RC
Cancer Immunol Immunother; 1999 Feb; 47(6):343-51. PubMed ID: 10203065
[TBL] [Abstract][Full Text] [Related]
13. Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.
Newmaster RS; Mylin LM; Fu TM; Tevethia SS
Virology; 1998 May; 244(2):427-41. PubMed ID: 9601511
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
Bright RK; Shearer MH; Pass HI; Kennedy RC
Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255
[TBL] [Abstract][Full Text] [Related]
15. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
Shearer MH; Bright RK; Kennedy RC
Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of CD8+ T cells in advanced-stage tumors and delay of disease progression following secondary immunization against an immunorecessive epitope.
Ryan CM; Schell TD
J Immunol; 2006 Jul; 177(1):255-67. PubMed ID: 16785521
[TBL] [Abstract][Full Text] [Related]
17. SV40 large tumor antigen associated synthetic peptides define native antigenic determinants and induce protective tumor immunity in mice.
Bright RK; Shearer MH; Kennedy RC
Mol Immunol; 1994 Oct; 31(14):1077-87. PubMed ID: 7523865
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid vaccination against virally induced tumors.
Bright RK; Shearer MH; Kennedy RC
Ann N Y Acad Sci; 1995 Nov; 772():241-51. PubMed ID: 8546399
[TBL] [Abstract][Full Text] [Related]
19. Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.
Shearer MH; Bright RK; Lanford RE; Kennedy RC
Clin Exp Immunol; 1993 Feb; 91(2):266-71. PubMed ID: 7679059
[TBL] [Abstract][Full Text] [Related]
20. Immunization with soluble simian virus 40 large T antigen induces a specific response of CD3+ CD4- CD8+ cytotoxic T lymphocytes in mice.
Schirmbeck R; Zerrahn J; Kuhröber A; Kury E; Deppert W; Reimann J
Eur J Immunol; 1992 Mar; 22(3):759-66. PubMed ID: 1312473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
